These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 276626)

  • 21. Association of host immunity with 5-fluorouracil-initiated cure of plasmacytoma LPC-1 in BALB/c mice.
    Teller MN; Faanes RB
    Cancer Res; 1980 Aug; 40(8 Pt 1):2790-5. PubMed ID: 6966969
    [No Abstract]   [Full Text] [Related]  

  • 22. The allogeneic effect on tumor growth. I. Inhibition of a murine plasmacytoma, MOPC 315, by the graft-vs-host reaction.
    Osborne DP; Katz DH
    J Immunol; 1977 Apr; 118(4):1441-8. PubMed ID: 15034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloma cell immunoglobulin expression during in vivo growth in diffusion chambers: evidence for repetitive cycles of differentiation.
    Rohrer JW; Vasa K; Lynch RG
    J Immunol; 1977 Sep; 119(3):861-6. PubMed ID: 330758
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuraminidase sensitive antigenic determinants of plasma cell tumor membrane glycoproteins.
    Prat M; Landolfo S; Comoglio PM
    FEBS Lett; 1975 Mar; 51(1):351-4. PubMed ID: 47298
    [No Abstract]   [Full Text] [Related]  

  • 25. Isolation of a specific plasmacytoma tumor antigen, reactive both in humoral and cell mediated immunity.
    Kolb JP; Lespinats G; Poupon MF
    Ann Immunol (Paris); 1974; 125 C(5):835-45. PubMed ID: 4142374
    [No Abstract]   [Full Text] [Related]  

  • 26. Circulating tumor cells in murine myeloma.
    Warner TF; Moses HL; Fair DS; Krueger RG
    J Natl Cancer Inst; 1977 Apr; 58(4):983-92. PubMed ID: 845999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
    Haubeck HD; Kölsch E
    Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic and immunogenic properties of membrane proteins solubilized by sodium desoxycholate, papain digestion or high ionic strength.
    Prat M; Tarone G; Comoglio PM
    Immunochemistry; 1975 Jan; 12(1):9-17. PubMed ID: 1140821
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytotoxic T lymphocytes to murine plasmacytoma cells in allogeneic and syngeneic mice: H-2 antigens are essential in the induction and effector stages of CTL.
    Kaneko Y; Natsuume-Sakai S; Migita S
    J Immunol; 1978 Aug; 121(2):427-37. PubMed ID: 79604
    [No Abstract]   [Full Text] [Related]  

  • 30. Tumor immunity induced by preimmunization with BALB/c mouse myeloma protein.
    Freedman PM; Autry JR; Tokuda S; Williams RC
    J Natl Cancer Inst; 1976 Apr; 56(4):735-40. PubMed ID: 56452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of antigen by immunocytes. I. Effect of ligand valence on binding affinity of MOPC 315 cells for DNP conjugates.
    Bystryn JC; Siskind GW; Uhr JW
    J Exp Med; 1973 Feb; 137(2):301-16. PubMed ID: 4734402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Karyotypic evolution associated with loss of tumorigenicity.
    Shepard JS; Pettengill OS; Wurster-Hill DH; Sorenson GD
    J Natl Cancer Inst; 1979 Mar; 62(3):547-54. PubMed ID: 283284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of intraperitoneal pristane on established immunity to the adj-PC-5 plasmacytoma.
    Potter M; Walters JL
    J Natl Cancer Inst; 1973 Sep; 51(3):875-81. PubMed ID: 4743559
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cellular immunity in mouse plasmocytomas].
    Lespinats G; Poupon MF
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):755-65. PubMed ID: 5050876
    [No Abstract]   [Full Text] [Related]  

  • 35. Variable expression of membrane proteins among murine lymphoblastoid tumors as seen with sodium dodecyl sulfate-polyacrylamide gradient gel electrophoresis of [35S]methionine-labeled cell membranes.
    Malenka DJ; Rogan KM; Howe RC; Nelson RS; Wrobel CJ; Ahmed A; Humphreys RE
    Cancer Res; 1979 Dec; 39(12):4782-90. PubMed ID: 498108
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of 5-bromodeoxyuridine on mouse myeloma cells.
    Pettengill OS; Sorenson GD
    In Vitro; 1974; 10(5-6):274-80. PubMed ID: 4452560
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo administration of propranolol delays development of a murine plasmacytoma tumor.
    Grzanna R; Frondoza CG; Hung GL; Sastre A
    J Auton Nerv Syst; 1985 Dec; 14(4):397-401. PubMed ID: 4086728
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunosupression of the primary and secondary immune response by an IgM plasmacytoma (TEPC-183).
    Havas HF; Schiffman GD; Fenton M; Goodis A; Braverman S
    Immunology; 1979 Feb; 36(2):191-7. PubMed ID: 35463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on J-chain biosynthesis in tumours producing immunoglobulins in NZB mice.
    Kaji H
    Biochem J; 1976 Jun; 156(3):681-4. PubMed ID: 821482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse.
    Wolf JE; Faanes RB; Choi YS
    J Natl Cancer Inst; 1977 May; 58(5):1407-12. PubMed ID: 67213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.